Specifically, there were significantly higher rates of CYP2C19 PM in BP patients in comparison to MDD patients; among those participants with an S-allele, the rate of CYP2C19 PM phenotype was more than 10X higher in the BP vs. MDD. This evidence concerns the gene CYP2C19 and major depressive disorder.